About Us
Company Profile
Executive Management
Board of Directors
Clinical Advisory Board
Our Pipeline
Our Science
For Patients
Investors & Media
Overview
News & Press Releases
Presentations
Publications
Events
SEC Filings
Stock Quote & Chart
Executive Management
Board of Directors
Board Committees
Corporate Governance
Clinical Advisory Board
Analyst Coverage
RSS Feeds
Contact Us
Contact Us
About Us
Company Profile
Executive Management
Board of Directors
Clinical Advisory Board
Our Pipeline
Our Science
For Patients
Investors & Media
Overview
News & Press Releases
Presentations
Publications
Events
SEC Filings
Stock Quote & Chart
Executive Management
Board of Directors
Board Committees
Corporate Governance
Clinical Advisory Board
Analyst Coverage
RSS Feeds
Contact Us
Contact Us
Home
>
News
All
|
News
|
Press Release
|
Events
New Study By University Of Maryland School Of Medicine Researchers Finds Promising Results For Treatment
February 17, 2016
SAB Biotherapeutics Produces New Human Antibody Treatment For MERS-CoV
February 17, 2016
Internationally Recognized Experts Appointed To SAB Biotherapeutics Scientific Advisory Board
January 19, 2016
Biotech Company Might Help Saudi Arabia With MERS
September 4, 2015
Development Foundation Invests In Growing SAB Biotherapeutics
January 6, 2015
SAB Biotherapeutics And U.S. Army Team Up To Treat Hantavirus
December 3, 2014
SAB Biotherapeutics, Inc. Producing Human Antibodies To Combat Disease
November 28, 2014
Human Antibodies Produced In DNA-Vaccinated Cows Protect In Lethal Models Of Hantavirus
November 26, 2014
Human Antibodies Produced In DNA-Vaccinated Cows Protect In Lethal Models Of Hantavirus Pulmonary Syndrome
November 26, 2014
GMO Cattle Produce Serum To Fight Hantavirus – Is Ebola Next?
November 26, 2014
Cows With Human Chromosomes Enlist To Fight Hantavirus
November 26, 2014
Animal Biotech Industry Thrives In State’s Climate
September 16, 2014
Previous
Next